Blue Water Life Science Fund
4
116M
4
1
- Areas of investment
Summary
The usual cause for the fund is to invest in rounds with 9 partakers. Despite the Blue Water Life Science Fund, startups are often financed by 5AM Ventures, Novartis, Jazz Venture Partners. The meaningful sponsors for the fund in investment in the same round are Trustbridge Partners, Temasek Holdings, Novartis.
The important activity for fund was in 2019. The fund is generally included in less than 2 deals every year. The usual things for fund are deals in the range of 50 - 100 millions dollars.
Among the most popular portfolio startups of the fund, we may highlight Pear Therapeutics. Besides, a startup requires to be at the age of 6-10 years to receive the investment from the fund. Among the most successful fund investment fields, there are Biotechnology, Therapeutics.
Investments analytics
Analytics
- Total investments
- 4
- Lead investments
- 0
- Exits
- 1
- Investments by industry
- Biotechnology (3)
- Pharmaceutical (2)
- Health Care (2)
- Medical (2)
- Health Diagnostics (2) Show 6 more
- Investments by region
-
- United States (4)
- Peak activity year
- 2019
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 13
- Avg. valuation at time of investment
- 375M
- Group Appearance index
- 1.00
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Karius | 02 May 2024 | Biotechnology, Information Technology, Genetics, Life Science | Late Stage Venture | 100M | United States, California, Redwood City |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.